IL200470A - Annals of 4- (pyrolopyridinyl) pyrimidine-2-illamine - Google Patents
Annals of 4- (pyrolopyridinyl) pyrimidine-2-illamineInfo
- Publication number
- IL200470A IL200470A IL200470A IL20047009A IL200470A IL 200470 A IL200470 A IL 200470A IL 200470 A IL200470 A IL 200470A IL 20047009 A IL20047009 A IL 20047009A IL 200470 A IL200470 A IL 200470A
- Authority
- IL
- Israel
- Prior art keywords
- pyrrolopyridinyl
- pyrimidin
- ylamine derivatives
- ylamine
- derivatives
- Prior art date
Links
- REPODGYKGOPEIK-UHFFFAOYSA-N 4-(1h-pyrrolo[3,2-b]pyridin-2-yl)pyrimidin-2-amine Chemical class NC1=NC=CC(C=2NC3=CC=CN=C3C=2)=N1 REPODGYKGOPEIK-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102007008419A DE102007008419A1 (de) | 2007-02-21 | 2007-02-21 | 4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate |
| PCT/EP2008/000634 WO2008101587A1 (de) | 2007-02-21 | 2008-01-28 | 4-(pyrrolopyridinyl)-pyrimidin-2-yl-amin-derivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL200470A0 IL200470A0 (en) | 2010-04-29 |
| IL200470A true IL200470A (en) | 2014-02-27 |
Family
ID=39410261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL200470A IL200470A (en) | 2007-02-21 | 2009-08-18 | Annals of 4- (pyrolopyridinyl) pyrimidine-2-illamine |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8293891B2 (enExample) |
| EP (1) | EP2121682B1 (enExample) |
| JP (1) | JP5508026B2 (enExample) |
| KR (1) | KR20090110948A (enExample) |
| CN (1) | CN101616918A (enExample) |
| AR (1) | AR065390A1 (enExample) |
| AU (1) | AU2008217297B2 (enExample) |
| BR (1) | BRPI0808167A2 (enExample) |
| CA (1) | CA2678691C (enExample) |
| DE (1) | DE102007008419A1 (enExample) |
| DK (1) | DK2121682T3 (enExample) |
| EA (1) | EA200901100A1 (enExample) |
| ES (1) | ES2427594T3 (enExample) |
| IL (1) | IL200470A (enExample) |
| MX (1) | MX2009008864A (enExample) |
| PT (1) | PT2121682E (enExample) |
| WO (1) | WO2008101587A1 (enExample) |
| ZA (1) | ZA200906539B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2026654A4 (en) * | 2006-05-26 | 2013-07-17 | Univ Louisville Res Found | MACROPHAGE MIGRATION HEMMFAKTOR ANTAGONISTS AND USE METHOD THEREFOR |
| US9162987B2 (en) | 2009-09-24 | 2015-10-20 | University Of Louisville Research Foundation, Inc. | Iodo pyrimidine derivatives useful for the treatment of macrophage migration inhibitory factor (MIF)-implicated diseases and conditions |
| US9155790B2 (en) | 2010-05-20 | 2015-10-13 | University of Lousiville Research Foundation, Inc. | Methods and compositions for modulating ocular damage |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
| GB9904387D0 (en) | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
| RU2292904C2 (ru) * | 2001-01-09 | 2007-02-10 | Мерк Патент Гмбх | Комбинированная терапия, использующая ингибиторы рецептора тирозинкиназы и ингибиторы ангиогенезиса |
| GB0308466D0 (en) | 2003-04-11 | 2003-05-21 | Novartis Ag | Organic compounds |
| WO2006038001A1 (en) * | 2004-10-06 | 2006-04-13 | Celltech R & D Limited | Aminopyrimidine derivatives as jnk inhibitors |
-
2007
- 2007-02-21 DE DE102007008419A patent/DE102007008419A1/de not_active Withdrawn
-
2008
- 2008-01-28 CN CN200880005794A patent/CN101616918A/zh active Pending
- 2008-01-28 EP EP08707340.9A patent/EP2121682B1/de not_active Not-in-force
- 2008-01-28 MX MX2009008864A patent/MX2009008864A/es not_active Application Discontinuation
- 2008-01-28 KR KR1020097019557A patent/KR20090110948A/ko not_active Withdrawn
- 2008-01-28 AU AU2008217297A patent/AU2008217297B2/en not_active Ceased
- 2008-01-28 WO PCT/EP2008/000634 patent/WO2008101587A1/de not_active Ceased
- 2008-01-28 BR BRPI0808167-0A patent/BRPI0808167A2/pt not_active IP Right Cessation
- 2008-01-28 ES ES08707340T patent/ES2427594T3/es active Active
- 2008-01-28 DK DK08707340.9T patent/DK2121682T3/da active
- 2008-01-28 PT PT87073409T patent/PT2121682E/pt unknown
- 2008-01-28 US US12/527,671 patent/US8293891B2/en not_active Expired - Fee Related
- 2008-01-28 CA CA2678691A patent/CA2678691C/en not_active Expired - Fee Related
- 2008-01-28 EA EA200901100A patent/EA200901100A1/ru unknown
- 2008-01-28 JP JP2009550227A patent/JP5508026B2/ja not_active Expired - Fee Related
- 2008-02-20 AR ARP080100678A patent/AR065390A1/es unknown
-
2009
- 2009-08-18 IL IL200470A patent/IL200470A/en active IP Right Grant
- 2009-09-18 ZA ZA200906539A patent/ZA200906539B/xx unknown
-
2012
- 2012-06-19 US US13/527,008 patent/US8557977B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PT2121682E (pt) | 2013-10-17 |
| WO2008101587A1 (de) | 2008-08-28 |
| BRPI0808167A2 (pt) | 2014-07-08 |
| MX2009008864A (es) | 2009-08-28 |
| US8293891B2 (en) | 2012-10-23 |
| ES2427594T3 (es) | 2013-10-31 |
| JP2010519230A (ja) | 2010-06-03 |
| AU2008217297A1 (en) | 2008-08-28 |
| DE102007008419A1 (de) | 2008-08-28 |
| CA2678691A1 (en) | 2008-08-28 |
| US20120264999A1 (en) | 2012-10-18 |
| DK2121682T3 (da) | 2013-09-08 |
| EP2121682B1 (de) | 2013-07-10 |
| IL200470A0 (en) | 2010-04-29 |
| JP5508026B2 (ja) | 2014-05-28 |
| AR065390A1 (es) | 2009-06-03 |
| EA200901100A1 (ru) | 2010-02-26 |
| ZA200906539B (en) | 2010-06-30 |
| US8557977B2 (en) | 2013-10-15 |
| US20110092527A1 (en) | 2011-04-21 |
| KR20090110948A (ko) | 2009-10-23 |
| EP2121682A1 (de) | 2009-11-25 |
| CA2678691C (en) | 2015-09-08 |
| AU2008217297B2 (en) | 2013-01-17 |
| CN101616918A (zh) | 2009-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL205425A0 (en) | Novel pyrimidine derivatives | |
| IL210176A0 (en) | Substituted pyrimidone derivatives | |
| IL205759A0 (en) | Isoxazolo-pyridine derivatives | |
| IL205753A0 (en) | Isoxazolo-pyridazine derivatives | |
| IL202020A0 (en) | Spiroindolinone derivatives | |
| SI2154967T1 (sl) | Derivati pirimidina | |
| ZA201006104B (en) | Substituted xanthine derivatives | |
| ZA201001058B (en) | Quinazolinamide derivatives | |
| ZA201000431B (en) | Indazolamide derivatives | |
| IL205755A0 (en) | Isoxazolo-pyrazine derivatives | |
| IL200618A0 (en) | Aza-pyridopyrimidinone derivatives | |
| IL201446A0 (en) | Heteroarylamide pyrimidone compounds | |
| IL210613A0 (en) | Novel acylaminobenzamide derivatives | |
| ZA201005382B (en) | Substituted heteroarylamide diazepinopyrimidone derivatives | |
| IL202667A0 (en) | Isoxazole-imidazole derivatives | |
| IL207191A0 (en) | Substituted heteroaylamide oxazepyrimidone derivatives | |
| EP2141168A4 (en) | HETEROARYLATED DERIVATIVES | |
| PL2245028T3 (pl) | Pochodne 5-aminocyklilometyloksazolidyn-2-onu | |
| EP2133347A4 (en) | 1-BIARYLAZETIDINONDERIVATE | |
| IL202463A0 (en) | Sulfonyl-quinoline derivatives | |
| IL202159A0 (en) | Piperidine-amide derivatives | |
| ZA200906539B (en) | 4-(Pyrrolopyridinyl)pyrimidin-2-Ylamine Derivatives | |
| ZA201002218B (en) | Thiadiazinone derivatives | |
| GB0702266D0 (en) | 7-Azaindoe derivatives | |
| HU0700417D0 (en) | Sulfonyl-quinoline derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |